Sinopharm Group's market value is the price at which a share of Sinopharm Group trades on a public exchange. It measures the collective expectations of Sinopharm Group Co investors about its performance. Sinopharm Group is trading at 2.35 as of the 13th of February 2026. This is a No Change since the beginning of the trading day. The stock's lowest day price was 2.35. With this module, you can estimate the performance of a buy and hold strategy of Sinopharm Group Co and determine expected loss or profit from investing in Sinopharm Group over a given investment horizon. Check out Sinopharm Group Correlation, Sinopharm Group Volatility and Sinopharm Group Performance module to complement your research on Sinopharm Group.
Please note, there is a significant difference between Sinopharm Group's value and its price as these two are different measures arrived at by different means. Investors typically determine if Sinopharm Group is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. In contrast, Sinopharm Group's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.
Sinopharm Group 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Sinopharm Group's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Sinopharm Group.
0.00
11/15/2025
No Change 0.00
0.0
In 3 months and 1 day
02/13/2026
0.00
If you would invest 0.00 in Sinopharm Group on November 15, 2025 and sell it all today you would earn a total of 0.00 from holding Sinopharm Group Co or generate 0.0% return on investment in Sinopharm Group over 90 days. Sinopharm Group is related to or competes with Shanghai Pharmaceuticals, Matsumotokiyoshi, Sysmex Corp, Sonic Healthcare, Sonic Healthcare, Guangzhou Baiyunshan, and ConvaTec Group. Ltd., together with its subsidiaries, engages in the wholesale and retail of pharmaceutical and medical devices and heal... More
Sinopharm Group Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Sinopharm Group's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Sinopharm Group Co upside and downside potential and time the market with a certain degree of confidence.
Today, many novice investors tend to focus exclusively on investment returns with little concern for Sinopharm Group's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Sinopharm Group's standard deviation. In reality, there are many statistical measures that can use Sinopharm Group historical prices to predict the future Sinopharm Group's volatility.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Sinopharm Group's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Sinopharm Group owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.11, which indicates the firm had a -0.11 % return per unit of risk over the last 3 months. Sinopharm Group Co exposes sixteen different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Sinopharm Group's Variance of 1.05, coefficient of variation of (960.29), and Risk Adjusted Performance of (0.08) to confirm the risk estimate we provide. The entity has a beta of -0.2, which indicates not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Sinopharm Group are expected to decrease at a much lower rate. During the bear market, Sinopharm Group is likely to outperform the market. At this point, Sinopharm Group has a negative expected return of -0.12%. Please make sure to validate Sinopharm Group's treynor ratio and rate of daily change , to decide if Sinopharm Group performance from the past will be repeated at some point in the near future.
Auto-correlation
-0.06
Very weak reverse predictability
Sinopharm Group Co has very weak reverse predictability. Overlapping area represents the amount of predictability between Sinopharm Group time series from 15th of November 2025 to 30th of December 2025 and 30th of December 2025 to 13th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Sinopharm Group price movement. The serial correlation of -0.06 indicates that barely 6.0% of current Sinopharm Group price fluctuation can be explain by its past prices.
Other Information on Investing in Sinopharm Pink Sheet
Sinopharm Group financial ratios help investors to determine whether Sinopharm Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Sinopharm with respect to the benefits of owning Sinopharm Group security.